• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GIP

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Vizit Graphs Tag Cloud

TNF METFORMIN STREPTOCOCCUS PNEUMONIAE STAPHYLOCOCCUS AUREUS SOD1 ERBB-2 DIABETES MELLITUS INFLAMMATION TP53 CASP3 IL17A CD4 RECEPTOR PARKINSON DISEASE AUTOPHAGY AGING BREAST CANCER IL6 ALZHEIMER'S DISEASE TH17 CELLS NEURODEGENERATIVE DISORDERS PSEUDOMONAS AERUGINOSA ESCHERICHIA COLI HELICOBACTER PYLORI DOXORUBICIN CELL DIFFERENTIATION CANCER CELL PROLIFERATION LISTERIA MONOCYTOGENES RHEUMATOID ARTHRITIS IL23A CELL DEATH CELL DIVISION CLOSTRIDIUM DIFFICILE FOXP3 REMICADE CANDIDA ALBICANS IFNG INSULIN APOPTOTIC PROCESS PORPHYROMONAS GINGIVALIS CTLA4 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE ANGIOGENESIS IMMUNE RESPONSE

© 2019 Biovista Vizit All Rights Reserved.